Immediate Impact
6 from Science/Nature 62 standout
Citing Papers
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Cancer statistics, 2023
2023 Standout
Works of Sekwon Jang being referenced
Phase 1 dose escalation study of MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors.
2021
Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204).
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sekwon Jang | 391 | 157 | 260 | 41 | 696 | |
| R. Angelo de Claro | 409 | 195 | 193 | 37 | 759 | |
| Sachin Shah | 282 | 68 | 211 | 25 | 721 | |
| Samuel M. Rubinstein | 277 | 75 | 132 | 42 | 597 | |
| Ankit Kansagra | 339 | 114 | 198 | 65 | 615 | |
| R. Jackson Forcier | 426 | 99 | 206 | 18 | 784 | |
| Shruti Agrawal | 435 | 131 | 116 | 32 | 694 | |
| James E. Ward | 348 | 63 | 332 | 16 | 699 | |
| Rebecca S. Tidwell | 333 | 137 | 120 | 38 | 580 | |
| Rosa Giuliani | 507 | 127 | 159 | 31 | 767 | |
| Paul R. Massey | 351 | 277 | 118 | 30 | 749 |
All Works
Loading papers...